Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
批准号:
7168804
负责人:
Kerry S Campbell
金额:
$26.28万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-03-01 至 2009-01-31
关键词:
AddressBindingBiochemicalBiologicalBiological ModelsBiological ProcessCD158dCD94 AntigenCell LineCell modelCellsConditionCytolysisCytoplasmic TailDataDeciduaDetectionElementsEpitopesEquilibriumEventEvolutionFamilyFamily memberGoalsHLA G antigenHumanImmunologic SurveillanceIndiumInterferon Type IIInterferonsKIR2DL4 receptorKiller CellsLigandsLinkLymphocyteMHC Class I GenesMalignant NeoplasmsMapsMediatingMessenger RNAMolecularNK Cell ActivationNamesNatural Killer CellsPlayPregnancyPregnant WomenPrimatesProductionProteinsRestRetroviridaeRoleSignal TransductionSignal Transduction PathwaySignaling ProteinSourceStructureTYROBP geneTechniquesTestingTransmembrane DomainTrophoblastic NeoplasmsViralVirusVirus Diseasesbasecytokinecytotoxicityfetalmemberneoplastic cellprogramsreceptorreceptor couplingresponsetrophoblasttumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): KIR2DL4 (2DL4; CD158d) is structurally and functionally unique among members of the killer cell Ig-like receptor (KIR) family in humans. Studies indicate that 2DL4 is the only KIR for which mRNA is expressed in all NK cell clones analyzed, which strongly indicates that it serves a biologically important function. It is also the only KIR that reportedly binds HLA-G, which is almost exclusively expressed on fetal-derived trophoblasts that infiltrate the maternal decidua in pregnant women. Thus, 2DL4 has been proposed to play an important role during pregnancy, although additional functional roles are clearly possible, particularly in cancer and virus infection.
2DL4 also stands out as the only NK cell activating receptor that reportedly triggers interferon (IFN)gamma production, but not target cell cytotoxicity in resting human NK cells. In contrast, other NK cell activating receptors initiate a functional response program that leads to both IFNgamma production and cytotoxicity. We hypothesize that the distinctive functional attributes of 2DL4 result from physical linkage to a unique transmembrane accessory protein that couples the receptor to signal transduction cascades that differ from those triggered by other activating receptors. Our preliminary data support this hypothesis. We propose to define the molecular basis for the distinctive functional response program activated by 2DL4 and define the elements that differ from those triggered by other NK cell activating receptors that also stimulate cytolytic responses. The results will allow us to define the molecular basis for activating distinct functional response programs in NK cells when they encounter trophoblasts, tumor cells, or virus infected cells. We will pursue the following specific aims to achieve this goal:
1 How do structural elements of KIR2DL4 contribute to its unique functions?
2. What accessory signaling protein is associated with the transmembrane domain of KIR2DL4 to transduce intracellular signals?
3. What are the molecular mechanisms by which KIR2DL4 transduces unique activation signals inhuman NK cells?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
-
批准号:10319570
-
项目类别:
-
资助金额:$50.65万
-
财政年份:2020
-
负责人:Kerry S Campbell
-
依托单位:
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
-
批准号:10544158
-
项目类别:
-
资助金额:$50.26万
-
财政年份:2020
-
负责人:Kerry S Campbell
-
依托单位:
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
-
批准号:10078249
-
项目类别:
-
资助金额:$51.02万
-
财政年份:2020
-
负责人:Kerry S Campbell
-
依托单位:
Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders
-
批准号:9038558
-
项目类别:
-
资助金额:$66.25万
-
财政年份:2016
-
负责人:Kerry S Campbell
-
依托单位:
Characterization of Type-2 Cytokine-Producing NK Cells
-
批准号:8073248
-
项目类别:
-
资助金额:$1.07万
-
财政年份:2010
-
负责人:Kerry S Campbell
-
依托单位:
Characterization of Type-2 Cytokine-Producing NK Cells
-
批准号:7860305
-
项目类别:
-
资助金额:$27.61万
-
财政年份:2009
-
负责人:Kerry S Campbell
-
依托单位:
Characterization of Type-2 Cytokine-Producing NK Cells
-
批准号:7707072
-
项目类别:
-
资助金额:$21.7万
-
财政年份:2009
-
负责人:Kerry S Campbell
-
依托单位:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
-
批准号:7332209
-
项目类别:
-
资助金额:$26.28万
-
财政年份:2004
-
负责人:Kerry S Campbell
-
依托单位:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
-
批准号:6860141
-
项目类别:
-
资助金额:$27.78万
-
财政年份:2004
-
负责人:Kerry S Campbell
-
依托单位:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
-
批准号:7013613
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2004
-
负责人:Kerry S Campbell
-
依托单位:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
-
批准号:6724624
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2004
-
负责人:Kerry S Campbell
-
依托单位:
NEGATIVE SIGNALLING BY KILLER CELL INHIBITORY RECEPTORS
-
批准号:6194275
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Molecular Regulation of Inhibitory Killer Cell Ig-like Receptors
-
批准号:8211081
-
项目类别:
-
资助金额:$30.37万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Molecular Regulation of Inhibitory Killer Cell Ig-like Receptors
-
批准号:7779658
-
项目类别:
-
资助金额:$30.68万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
NEGATIVE SIGNALLING BY KILLER CELL INHIBITORY RECEPTORS
-
批准号:6377620
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
NEGATIVE SIGNALLING BY KILLER CELL INHIBITORY RECEPTORS
-
批准号:6514230
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Molecular Regulation of Inhibitory Killer Cell Ig-like Receptors
-
批准号:8606416
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Molecular Regulation of Inhibitory Killer Cell Ig-like Receptors
-
批准号:8433503
-
项目类别:
-
资助金额:$28.61万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Negative Signalling by Killer Ig-like Receptors
-
批准号:7393731
-
项目类别:
-
资助金额:$28.84万
-
财政年份:2000
-
负责人:Kerry S Campbell
-
依托单位:
Negative Signalling by Killer Ig-like Receptors
-
批准号:7208993
-
项目类别:
-
资助金额:$28.84万
-
财政年份:1999
-
负责人:Kerry S Campbell
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: